Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Trivastal
| Field | Information |
|---|---|
| Medication Name | Trivastal |
| Generic Name | Piribedil |
| Purpose | Treatment of Parkinson’s disease and age-related cognitive decline. |
| Mechanism of Action | Dopamine D2 and D3 receptor agonist, and alpha-2 adrenergic receptor antagonist. |
| Dosage Forms | Oral tablets |
| Available Strengths | 50 mg |
| Dosage Frequency | Usually two to three times daily, as directed by a healthcare provider. |
| Common Side Effects | Nausea, vomiting, orthostatic hypotension (dizziness upon standing), drowsiness, confusion, hallucinations |
| Serious Side Effects | Sudden sleep onset, cardiac valve fibrosis, impulse control disorders (e.g., compulsive gambling, hypersexuality) |
| Drug Interactions | Neuroleptics (antipsychotics), antiemetics (metoclopramide), antihypertensives, alcohol |
| Important Notes | May cause orthostatic hypotension; rise slowly from sitting or lying position. Report any new or worsening impulse control symptoms to your doctor. |
| Storage | Store at room temperature away from moisture and light. |
| Missed Dose | Take as soon as you remember; skip if it’s almost time for your next dose. Do not double the dose. |
| Alternatives | Levodopa/Carbidopa, Pramipexole (Mirapex), Ropinirole (Requip), Amantadine |
Trivastal Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Levodopa/Carbidopa (Sinemet) | Dopamine precursor | Converts to dopamine in the brain. Often considered first-line treatment for Parkinson’s. |
| Pramipexole (Mirapex) | Dopamine D2 and D3 receptor agonist | Directly stimulates dopamine receptors in the brain. |
| Ropinirole (Requip) | Dopamine D2 and D3 receptor agonist | Similar mechanism to Pramipexole. |
| Amantadine | NMDA receptor antagonist, increases dopamine release | Can help control dyskinesias (involuntary movements) associated with levodopa. |
Trivastal Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Sudden sleep onset |
| Vomiting | Cardiac valve fibrosis |
| Orthostatic hypotension (dizziness upon standing) | Impulse control disorders (compulsive gambling, hypersexuality, etc.) |
| Drowsiness | Hallucinations |
Trivastal Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Parkinson’s Disease | 50 mg | 50 mg two to three times daily | Take with food to minimize nausea. Dosage adjusted based on individual response. |
| Age-Related Cognitive Decline | 50 mg | 50 mg two to three times daily | Take as directed by your physician. Monitor for improvement or side effects. |
